Los Angeles Capital Management LLC Biomarin Pharmaceutical Inc Transaction History

Los Angeles Capital Management LLC

$28.5 Billion
Q3 2025

A detailed history of Los Angeles Capital Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 1,332,398 shares of BMRN stock, worth $72.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

1,332,398

Previous 278,189 378.95%

Holding current value

$72.9 Million

Previous $15.3 Million 371.89%

% of portfolio

0.25%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$52.62 - $61.93 $55.5 Million - $65.3 Million	1,054,209 Added 378.95%	1,332,398 $72.2 Million
Q2 2025 Aug 06, 2025	BUY	$54.08 - $68.32 $7.42 Million - $9.37 Million	137,135 Added 97.22%	278,189 $15.3 Million
Q1 2025 May 05, 2025	BUY	$61.25 - $72.83 $6.28 Million - $7.47 Million	102,525 Added 266.1%	141,054 $9.97 Million
Q4 2024 Feb 04, 2025	BUY	$61.93 - $70.49 $1.76 Million - $2 Million	28,431 Added 281.55%	38,529 $2.53 Million
Q3 2024 Nov 04, 2024	BUY	$69.02 - $93.84 $696,963 - $947,596	10,098 New	10,098 $709,000

Q4 2023 Feb 06, 2024	BUY	$76.22 - $98.51 $526,756 - $680,802	6,911 New	6,911 $666,000
Q2 2023 Aug 03, 2023	SELL	$86.68 - $100.3 $1.18 Million - $1.36 Million	-13,583 Reduced 17.94%	62,126 $5.39 Million
Q1 2023 May 04, 2023	SELL	$87.74 - $117.27 $106,340 - $142,131	-1,212 Reduced 1.58%	75,709 $7.36 Million
Q4 2022 Feb 06, 2023	BUY	$80.93 - $108.63 $6.23 Million - $8.36 Million	76,921 New	76,921 $7.96 Million
Q3 2020 Nov 02, 2020	SELL	$71.87 - $131.03 $975,275 - $1.78 Million	-13,570 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$79.55 - $124.22 $206,989 - $323,220	2,602 Added 23.72%	13,570 $1.67 Million
Q1 2020 May 04, 2020	SELL	$71.37 - $96.85 $284,052 - $385,463	-3,980 Reduced 26.63%	10,968 $927,000
Q4 2019 Feb 07, 2020	BUY	$64.27 - $86.37 $960,707 - $1.29 Million	14,948 New	14,948 $1.26 Million
Q2 2019 Jul 29, 2019	SELL	$80.35 - $93.9 $1.02 Million - $1.19 Million	-12,688 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$84.2 - $98.62 $64,834 - $75,937	-770 Reduced 5.72%	12,688 $1.13 Million
Q4 2018 Feb 11, 2019	SELL	$80.14 - $106.07 $1.39 Million - $1.84 Million	-17,360 Reduced 56.33%	13,458 $1.15 Million
Q3 2018 Nov 05, 2018	BUY	$93.92 - $105.72 $1.27 Million - $1.42 Million	13,470 Added 77.65%	30,818 $2.99 Million
Q2 2018 Jul 31, 2018	BUY	$76.01 - $99.03 $921,241 - $1.2 Million	12,120 Added 231.83%	17,348 $1.63 Million
Q1 2018 Apr 27, 2018	SELL	$77.67 - $92.63 $168,543 - $201,007	-2,170 Reduced 29.33%	5,228 $424,000
Q4 2017 Feb 05, 2018	SELL	$80.76 - $95.13 $5.34 Million - $6.29 Million	-66,153 Reduced 89.94%	7,398 $660,000
Q3 2017 Nov 06, 2017	BUY	$80.6 - $94.95 $3.25 Million - $3.83 Million	40,357 Added 121.58%	73,551 $6.85 Million
Q2 2017 Aug 09, 2017	BUY	N/A	33,194	33,194 $3.02 Million

Others Institutions Holding BMRN

# of Institutions

669

Shares Held

182M

Call Options Held

1.52M

Put Options Held

1.01M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Biomarin Pharmaceutical Inc Transaction History